相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PharmVar GeneFocus: CYP2D6
Charity Nofziger et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Standardizing CYP2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group
Kelly E. Caudle et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2020)
A Scoping Review of the Evidence Behind Cytochrome P450 2D6 Isoenzyme Inhibitor Classifications
Emily J. Cicali et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
The Implausibility of Neonatal Opioid Toxicity from Breastfeeding
Jonathan Zipursky et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Safety Issues of Pharmacological Acute Pain Treatment in Children
Frederique Rodieux et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
CYP2D6-guided opioid therapy improves pain control in CYP2D6 intermediate and poor metabolizers: a pragmatic clinical trial
D. Max Smith et al.
GENETICS IN MEDICINE (2019)
OPRM1 A118G Polymorphisms and Its Role in Opioid Addiction: Implication on Severity and Treatment Approaches
Malik Mumtaz Tagi et al.
PHARMACOGENOMICS & PERSONALIZED MEDICINE (2019)
When the Safe Alternative Is Not That Safe: Tramadol Prescribing in Children
Frederique Rodieux et al.
FRONTIERS IN PHARMACOLOGY (2018)
Review of Opioid Pharmacogenetics and Considerations for Pain Management
Aniwaa Owusu Obeng et al.
PHARMACOTHERAPY (2017)
Current Concepts in Methadone Metabolism and Transport
Evan D. Kharasch
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2017)
Pharmacogenetics for Safe Codeine Use in Sickle Cell Disease
Roseann S. Gammal et al.
PEDIATRICS (2016)
Hydrocodone in postoperative personalized pain management: Pro-drug or drug?
M. Elaine Stauble et al.
CLINICA CHIMICA ACTA (2014)
Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450 2D6 Genotype and Codeine Therapy: 2014 Update
K. R. Crews et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2014)
Development and use of active clinical decision support for preemptive pharmacogenomics
Gillian C. Bell et al.
JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION (2014)
Codeine-related adverse drug reactions in children following tonsillectomy: A prospective study
Cynthia A. Prows et al.
LARYNGOSCOPE (2014)
Contribution of oxycodone and its metabolites to the overall analgesic effect after oxycodone administration
Romina Klimas et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2013)
Do CYP2D6 genotypes reflect oxycodone requirements for cancer patients treated for cancer pain? A cross-sectional multicentre study
Trine Naalsund Andreassen et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2012)
More Codeine Fatalities After Tonsillectomy in North American Children
Lauren E. Kelly et al.
PEDIATRICS (2012)
Cannabidiol, a Major Phytocannabinoid, As a Potent Atypical Inhibitor for CYP2D6
Satoshi Yamaori et al.
DRUG METABOLISM AND DISPOSITION (2011)
Near-fatal tramadol cardiotoxicity in a CYP2D6 ultrarapid metabolizer
Ahmed Elkalioubie et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Human Mu Opioid Receptor (OPRM1 A118G) polymorphism is associated with brain mu-opioid receptor binding potential in smokers
Riju Ray et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Uniform assessment and ranking of opioid Mu receptor binding constants for selected opioid drugs
Donna A. Volpe et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2011)
Impact of the CYP2D6 genotype on post-operative intravenous oxycodone analgesia
S. T. Zwisler et al.
ACTA ANAESTHESIOLOGICA SCANDINAVICA (2010)
Genetic polymorphisms and drug interactions modulating CYP2D6 and CYP3A activities have a major effect on oxycodone analgesic efficacy and safety
C. F. Samer et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Composite Functional Genetic and Comedication CYP2D6 Activity Score in Predicting Tamoxifen Drug Exposure Among Breast Cancer Patients
Silvana Borges et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2010)
The Hypoalgesic Effect of Oxycodone in Human Experimental Pain Models in Relation to the CYP2D6 Oxidation Polymorphism
Stine T. Zwisler et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2009)
Pharmacogenetics of Neonatal Opioid Toxicity Following Maternal Use of Codeine During Breastfeeding: A Case-Control Study
P. Madadi et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Risk to the Breast-Fed Neonate From Codeine Treatment to the Mother: A Quantitative Mechanistic Modeling Study
S. Willmann et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Can extremely low or high morphine formation from codeine be predicted prior to therapy initiation?
Joern Loetsch et al.
PAIN (2009)
Respiratory depression with tramadol in a patient with renal impairment and CYP2D6 gene duplication
Ulrike M. Stamer et al.
ANESTHESIA AND ANALGESIA (2008)
The CYP2D6 activity score: Translating genotype information into a qualitative measure of phenotype
A. Gaedigk et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Pharmacokinetics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplication
J. Kirchheiner et al.
PHARMACOGENOMICS JOURNAL (2007)
Concentrations of tramadol and O-desmethyltramadol enantiomers in different CYP2D6 genotypes
U. M. Stamer et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
The effect of CYP2D6 polymorphisms on the response to pain treatment for pediatric sickle cell pain crisis
David C. Brousseau et al.
JOURNAL OF PEDIATRICS (2007)
Pharmacokinetics and pharmacodynamics of oral oxycodone in healthy human subjects: Role of circulating active metabolites
Bojan Lalovic et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G
Y Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Codeine intoxication associated with ultrarapid CYP2D6 metabolism
Y Gasche et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Impact of CYP2D6 genotype on postoperative tramadol analgesia
UM Stamer et al.
PAIN (2003)
分享论文
